Licensed Vocational Nurse in Santa Clarita, CA Accepting Medicare

9 Licensed Vocational Nurse nurses found. Showing 1 - 9

Benjamin Munoz Pablo Jr., LVN Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 25350 Magic Mountain Pkwy Ste 300, Santa Clarita, CA 91355 Phone: 661-214-3063

Brittaney Marie Martinez, LVN Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 26460 Summit Cir, Santa Clarita, CA 91350 Phone: 661-254-6630

Amber Marie Leonard, LVN Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 28069 Magic Mountain Ln, Santa Clarita, CA 91387 Phone: 661-236-4189

Debra Kristine Love, Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 20008 Shadow Island Dr, Santa Clarita, CA 91351 Phone: 818-383-0395

Julianna Mukasa Namujuzi, LVN Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 18259 Arial Way, Santa Clarita, CA 91350 Phone: 818-221-8018

Keisa Christine Desouza, LVN Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 24625 Arch St, Santa Clarita, CA 91321 Phone: 661-288-2644

Julie Lynn Acebedo, Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 19308 Bension Dr, None, Santa Clarita, CA 91350 Phone: 714-856-0924

Lovina C. Anikwem, Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 28032 Eddie Ln, Santa Clarita, CA 91350 Phone: 661-607-3203

Mrs. Maria Moyer, LVN Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 24790 Valley St, Santa Clarita, CA 91321 Phone: 661-670-2020

News Archive

Puricore announces closure of its new USD 2.1 million debt facility

PuriCore plc (LSE: PURI), the life sciences company focused on developing and commercialising proprietary, green solutions that safely, effectively, and naturally kill infectious pathogens without causing harm to human health or the environment, today announces that it has closed on a new USD2.1 million debt facility with Republic First Bank.

Can-Fite provides update on Phase II clinical trial with drug candidate Namodenoson

Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer, liver and inflammatory diseases, today provided an update on its Phase II clinical trial with drug candidate Namodenoson in the treatment of advanced hepatocellular carcinoma in patients whose disease has progressed on sorafenib therapy.

New study finds inequalities in healthcare access, quality between best and worst-performing countries

Despite global improvements in healthcare quality and access over 25 years, inequalities between the best and worst-performing countries have grown.

Gene variants appear to alter features of alcohol dose-response relationship

Although estimates vary, scientists believe that 50 to 64 percent of the risk of alcohol use disorders (AUDs) is inherited. One way to identify this risk is through a person's subjective response to alcohol.

Read more Medical News

› Verified 5 days ago